Table 1.
Patient characteristics at the third vaccination.
| Median age at vaccination (range, years). | 56 (23–71) | |
| Median IgG (range, mg/dL) | 957 (173–2126) | |
| Median lymphocyte count (range, /µL) | 1814 (32–4700) | |
| Median duration (range) | ||
| Transplantation—third vaccine | 1842 (378–4279) | |
| Second vaccine—third vaccine | 219 (194–258) | |
| Sex | n | % |
| Female | 10 | 45 |
| Male | 12 | 55 |
| Conditioning | ||
| MAC; myeloablative conditioning | 6 | 27 |
| RIC; reduced-intensity conditioning | 16 | 73 |
| Disease | ||
| AML; acute myeloid leukemia | 8 | 36 |
| ALL; acute lymphoblastic leukemia | 6 | 27 |
| ML; malignant lymphoma | 5 | 23 |
| Others | 3 | 14 |
| Immunosuppressants | ||
| Tacrolimus alone | 1 | 5 |
| Tacrolimus + steroid | 1 | 5 |
| Cyclosporine A + steroid | 1 | 5 |
| Steroid alone | 2 | 9 |
| No use | 17 | 77 |